Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ) has issued an announcement.
Dr. Reddy’s Laboratories Ltd. has released an investor presentation detailing its unaudited financial results for the third quarter of fiscal year 2026, covering the period ended 31 December 2025. The disclosure, made under Indian securities listing regulations, is intended to update shareholders and market participants on the company’s consolidated performance under IFRS and forms part of its regular financial reporting and investor communication practices.
More about Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is an India-based pharmaceutical company that develops, manufactures and markets a wide range of generic medicines and active pharmaceutical ingredients, with a global presence including listings on Indian exchanges and the New York Stock Exchange.
Average Trading Volume: 81,308
Technical Sentiment Signal: Hold
Current Market Cap: 973.1B INR
For a thorough assessment of DRREDDY stock, go to TipRanks’ Stock Analysis page.